 |
 |
 |
 |
Types of Papers: (I) Research Articles of original research in all fields mentioned in Aims and Scope (max. 10 printed pages or 20 double spaced typewritten (ms) pages). (2) Review Articles on specialized topics within the scope of the journal. (3) Brief Reports, i.e. short articles on preliminary findings of immediate importance, or case reports of special relevance, will be published in the next available issue (max. 2 pp. or 4-5 ms pages). (4) Technical Notes which describe modifications or additions to pertinent techniques (max. 2 pp. or 4-5 ms pages). (5) Letters to the Editor which should be clear and concise, be of general or scientific interest or comment on a previously published paper.
Submission of Manuscripts: The preferred medium of submission is on disk with accompanying manuscript (see 'Electronic Manuscripts' below). Manuscripts are welcome from all countries but must be in English. Authors are not required to be members of the European Society for Analytical Cellular Pathology. A manuscript may only be submitted if it has been approved by all of the authors. Articles should report original research not previously published or being considered for publication elsewhere. Manuscript will be peer reviewed and the decision of the Editor as advised by reviewers is final. Unless manuscripts are resubmitted, in revised form, within 3 months they will be considered as new submissions. Submission of a manuscript to the Journal gives the publisher the right to publish that paper if it is accepted. The manuscripts (in triplicate) should be submitted to the Editor-in-Chief, Managing Editor or Co-Editor according to the author's geographic location. They must be typed with double spacing (including References, Tables and Figure legends) and on one side of the page only. Authors must include a letter giving the title, the name(s) of the author(s), and a brief description of the major points of the paper. Authors should give a list of persons outside their institutions whom they feel would be qualified to review their paper, when this is possible. Authors can also request that their paper be transmitted to specific members of the editorial board.
Electronie Manuscrips: Electronic manuscripts have the advantage that there is no need for the rekeying of text, thereby avoiding the possibility of introducing errors and resulting in reliable and fast delivery of proofs. The preferred storage medium is a 5.25 or 3.5 inch disk in MS-DOS format, although other systems are welcome, e.g., Macintosh (in this case, save your file in the usual manner, do not use the option 'save in MS-DOS format'). Your disk and (exactly matching) printed version (printout, hardcopy) should be submitted together to the accepting editor. In case of revision, the same procedure should be followed such that, on acceptance of the article, the file on disk and the printout are identical. Please specify the type of computer and word-processing package used (do not convert your textfile to plain ASCII). Ensure that the letter 'I' and digit ' I ' (also letter 'O' and digit '0') have been used properly, and format your article (tabs, indents, etc.) consistently. Characters not available on your word processor (Greek letters, mathematical symbols, etc.) should not be left open but indicated by a unique code (e.g. gralpha, @, #, etc., for the Greek letter alpha). Such codes should be used consistently throughout the entire text. Please make a list of such codes and provide a key. Do not allow your word processor to introduce word splits and do not use a 'justified' layout. Please adhere strictly to the general instructions on style/arrangement and, in particular, the reference style of the journal. Further information may be obtained from the Publisher.
Authors in Japan please note: if you would like information about how to have the English of your paper checked, corrected and improved (before submission), please contact our Tokyo office who will inform you of the services provided by language correctors: Elsevier Science Japan. 20-12 Yushima 3-chome, Bunkyo-ku, Tokyo 113; Tel.: (03)-3833-3821; Fax: (03)-3836-3064.
All questions arising after acceptance of the manuscript, especially those relating to proofs, should be directed to Elsevier Science Ireland Ltd., Bav 15, Shannon Industrial Estate, Shannon, Co. Clare, Ireland, Tel. +353(61)471944; fax +353(61)472144. Advertising Information: Advertising orders and enquiries may be sent to: Elsevier Science Publishers B.V., Advertising Depart- ment, P.O. Box 211, 1000 AE Amsterdam, The Netherlands, tel. +31(20)5153220, fax +31(20)6833041. In the UK: TG Scott & Son Ltd., attn Tim Blake/Vanessa Bird, Portland House, 21 Narborough Rd., Cosby, Leicestershire, LE9 5TA, UK, tel. (0533)753333, fax (0533)750522. In the USA and Canada: Weston Media Associates, attn Daniel Lipner, P.O. Box 1110, Greens Farms. CT 06436-1110. USA. tel. (203)2612500. fax (203)2610101.
Proofs and Reprints: one set of uncorrected proofs will be sent for checking to the corresponding author. Only printer's errors may be corrected: no changes in, or additions to, the edited manuscript will be accepted. Proofs must be returned to the Publisher within 2 days of receipt. Fifty reprints are provided free of charge. Additional copies (100 minimum) can be ordered at prices shown on the Reprint Order Form which will be sent with the proofs. Analytical Cellular Pathology has no page charges.
C) 1994, Elsevier Science Ireland Ltd. All Rights Reserved 0921-8912/1994/$07.00
No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without the prior written permission of the Publisher, Elsevier Science Ireland Ltd., Copyright and Permissions Department, Bay 15, Shannon Industrial Estate, Shannon, Co. Clare, Ireland.
No responsibility is assumed by the Publisher and/or the European Society for Analytical Cellular Pathology for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Because of the rapid advances in medical sciences, the Publisher recommends that independent verification of diagnoses and drug dosages should be made. Although all advertising material is expected to conform to ethical (medical) standards, inclusion in this publication does not constitute a guarantee or endorsement of the quality or value of such product or of the claims made of it by its manufacturer.
Printed in the United Kingdom
oo The paper used in this publication meets the requirements of ANSI/NISO 239.48-1992 (Permanence of Paper)
|
|
|
|